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Abstract
Background: M. africanum West African 2 constitutes an ancient lineage of the M. tuberculosis complex that commonly
causes human tuberculosis in West Africa and has an attenuated phenotype relative to M. tuberculosis.
Methodology/Principal Findings: In search of candidate genes underlying these differences, the genome of M. africanum
West African 2 was sequenced using classical capillary sequencing techniques. Our findings reveal a unique sequence,
RD900, that was independently lost during the evolution of two important lineages within the complex: the ‘‘modern’’ M.
tuberculosis group and the lineage leading to M. bovis. Closely related to M. bovis and other animal strains within the M.
tuberculosis complex, M. africanum West African 2 shares an abundance of pseudogenes with M. bovis but also with M.
africanum West African clade 1. Comparison with other strains of the M. tuberculosis complex revealed pseudogenes events
in all the known lineages pointing toward ongoing genome erosion likely due to increased genetic drift and relaxed
selection linked to serial transmission-bottlenecks and an intracellular lifestyle.
Conclusions/Significance: The genomic differences identified between M. africanum West African 2 and the other strains of
the Mycobacterium tuberculosis complex may explain its attenuated phenotype, and pave the way for targeted experiments
to elucidate the phenotypic characteristic of M. africanum. Moreover, availability of the whole genome data allows for
verification of conservation of targets used for the next generation of diagnostics and vaccines, in order to ensure similar
efficacy in West Africa.
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Introduction
Mycobacterium africanum causes up to half of human TB in West
Africa and displays differences in patient characteristics and
immunoepidemiological features with M. tuberculosis, as reviewed
earlier in this journal [1]. First described in 1968 in Dakar,
Senegal [2], M. africanum used to be classified using biochemical
methods, until unambiguous classification became possible using
molecular methods and two different lineages were identified, M.
africanum West African type 1, common to Eastern West Africa,
and M. africanum West African type 2 , common to Western West
Africa [3]. Additionally, it became clear that the former ‘‘East
African M. africanum’’ is genetically part of M. tuberculosis sensu stricto
[4]. The prevalence of M. africanum varies within West Africa, with
the highest prevalence of M. africanum West African 2 identified in
Guinea Bissau (51%, [5]) and the highest prevalence of – West
African 1 recorded in Benin (around 28%, [6]). While compar-
isons between prior prevalence estimates based on biochemical
speciation and current estimates based on molecular speciation
deserve caution, the prevalence of M. africanum appears to be
decreasing in Cameroon [7] and Senegal (unpublished results).
Comparisons between patients infected with M. africanum West
African 2 and M. tuberculosis suggest that M. africanum is somewhat
attenuated in its ability to cause disease in immunocompetent
hosts [8] and is more common in HIV co-infected patients relative
to M. tuberculosis in The Gambia [9], yet not in Ghana [10].
Moreover, patients infected with M. africanum West African 2, as
well as their household contacts, are less likely to mount an IFNg
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response to ESAT-6 than those infected with M. tuberculosis [11].
These two types of M. africanum, West African 1 and West African
2, are distinct sub-species within the M. tuberculosis complex
although it has been suggested that these clades are better
described as ecotypes of the M. tuberculosis complex rather than
sub-species [12]. M. africanum West African type 2 is phylogenet-
ically closer to the animal strains like M. bovis , with which it shares
deletions RD7, 8 and 10 [13,14,15], although an animal reservoir
for M. africanum West African type 2 has not been detected [16].
Subtractive hybridization of M. africanum West African type 1 and
type 2 from M. tuberculosis H37Rv revealed shared and unique
genomic differences [3], yet these experiments were not designed
to identify regions present in M. africanum but absent from M.
tuberculosis. Here we take advantage of available genomic
information for strains of the Mycobacterium tuberculosis complex
from different sequencing platforms to present and analyze the
first complete M. africanum West African type 2 genome, that of
clinical isolate GM041182 (here designated M. africanum
GM041182 in the remainder of this manuscript), detailing a novel
lineage-defining deletion and an array of species-specific pseudo-
genes.
Materials and Methods
Isolate
Mycobacterium africanum GM041182 was isolated in The Gambia
in 2004 from a 27 year old HIV uninfected male patient with 3+
smear positive pulmonary tuberculosis. This patient provided
written informed consent for participation in the TB Case Contact
cohort study, which had been approved by the joint Gambia
Government/MRC ethics committee. Moreover, the same ethics
committee approved genotyping of bacteria isolated from the
patients enrolled in this cohort, and the data were analyzed
anonymously. Primary isolation was done in an automated liquid
culture system (Bactec MGIT 960, BD) and drug susceptibility
testing for first line drugs on solid medium identified no resistance.
Genomic DNA was extracted from a single colony sub-culture
using the CTAB method [17] and genotyped using spoligotype
analysis [18] and PCR for Large Sequence Polymorphism RD702
[3].
Genome sequencing
The genome of Mycobacterium africanum GM041182 was
sequenced to approximately 10-fold shotgun coverage, comprising
92612 end sequences, from pOTW12 (with insert sizes 3–4 kb)
and pMAQ1Sac_BstXI (with insert sizes of 4–5 kb and 5–6 kb)
genomic shotgun libraries using big-dye terminator chemistry on
ABI3730 automated sequencers. End sequences from large insert
Fosmid libraries in pCC1Fos with an average insert size of 38–
42 kb provided scaffold information with approximately 0.2-fold
coverage from 2077 end sequences. A 454 FLX sequencing run
provided approximately 10-fold single-end shotgun coverage,
comprising 224,378 end sequences from 3kb DNA fragments. In
addition an Illumina GAII sequencing lane provided approxi-
mately 50-fold single-end shotgun sequence, comprising 6083237
end sequences from 200–300 bp fragments and 37 cycles of
sequencing. All repeat regions and gaps were bridged by read-
pairs or end-sequenced polymerase chain reaction (PCR) products
again sequenced with big dye terminator chemistry on ABI3700
capillary sequencers. The sequence was manipulated to the
‘Finished’ standard [19] and is deposited in EMBL/Genbank/
DDBJ under accession number FR878060.
Annotation and genome comparisons
Coding sequences were initially identified by using Glimmer3
[20] and then manually curated using Frameplot [21] and Artemis
[22]. All genes were annotated in Artemis using standard criteria
[23]. Genome comparisons were visualized in the Artemis
comparison tool [24]. Sequence clustering and analysis was
performed by using ClustalX 2.0 [25] and MEGA4 [26].
Genome-based phylogeny of the M. africanum
GM041182 isolate
To corroborate the phylogenetic position of the GM041182
isolate within the MTBC we took advantage of the availability of
Illumina GAIIx runs for different clinical strains representative of
the MTBC [27]. We mapped reads for each strain to the genome
of GM041182 using MAQ [28] and single nucleotide polymor-
phisms were called as described in Comas et al. 2010 [27]. A total
of 9,699 positions were identified to vary in at least one strain after
exclusion of positions with heterozygous calls or deletions (no
coverage positions). A phylogeny was inferred using the number of
nucleotide differences between strains as the distance measure and
Neighbour-joining as the reconstruction method, and 1,000
bootstrap pseudo-replicates were performed to assess the reliability
of the clades. Alternative molecular evolution models and
phylogenetic methods were not carried out, as a similar set of
strains was extensively analyzed before and no difference in
topology was observed between the different approaches [27]. All
the phylogenetic analyses were carried out using MEGA5 package
[29].
Identification of pseudogenes
A two step process was carried out to identify mutations that
either led to the pseudogenization of previously described genes or
generated new potential CDS in lineages of the MTBC. Because
the genomes of M. tuberculosis H37Rv and M. bovis AF2122/97
were completed by shotgun sequencing and their annotation
manually curated we used them to infer a first list of candidate
pseudogenes when compared to M. africanum GM041182. CDS
were designated as pseudogenes if they contain in the alignment of
Author Summary
Mycobacterium africanum, a close relative of M. tuberculo-
sis, is studied for the following reasons: M. africanum is
commonly isolated from West African patients with
tuberculosis yet has not spread beyond this region, it is
more common in HIV infected patients, and it is less likely
to lead to tuberculosis after one is exposed to an infectious
case. Understanding this organism’s unique biology gets a
boost from the decoding of its genome, reported in this
issue. For example, genome analysis reveals that M.
africanum contains a region shared with ‘‘ancient’’ lineages
in the M. tuberculosis complex and other mycobacterial
species, which was lost independently from both M.
tuberculosis and M. bovis. This region encodes a protein
involved in transmembrane transport. Furthermore, M.
africanum has lost genes, including a known virulence
gene and genes for vitamin synthesis, in addition to an
intact copy of a gene that may increase its susceptibility to
antibiotics that are insufficiently active against M. tubercu-
losis. Finally, the genome sequence and analysis reported
here will aid in the development of new diagnostics and
vaccines against tuberculosis, which need to take into
account the differences between M. africanum and other
species in order to be effective worldwide.
Genome Sequence of M. africanum West African 2
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homologous positions between the three strains either a frameshift
or nonsense mutation, were truncated by a deletion event, or
interrupted by a large insertion event. As a second step we focus on
the microevolution of the MTBC by assessing whether the events
leading to truncated or novel CDS were shared among strains of
the different lineages of the complex. We took advantage of the
availability of draft shotgun sequences of strains belonging to the
different lineages (see Supplementary Table S1 for a list of strains
and sources). The polymorphisms were corroborated in other
strains by blast searches and manual inspection of the alignments.
To assign evolutionary directionality to the changes we used as an
outgroup the M. canettii genome (accession number HE572590).
Results
General genome features and phylogenetic position of
the GM041182 isolate
General features of the M. africanum GM041182 genome are
unremarkable relative to other members of the M. tuberculosis
complex with a typical %G+C content (65.6%) and a genome size
(4,389,314 bp) between the usual values for M. bovis (4.34–
4.37 Mbp) and M. tuberculosis (4.40–4.42 Mbp). The M. africanum
GM041182 genome is also collinear with those of M. bovis and M.
tuberculosis and shares the majority of coding sequences (CDSs).
Identification of CDSs present in M. bovis and M. tuberculosis but
absent from strains of M. africanum has been presented in several
publications to date so will not be further detailed here [3,30,31].
However, the availability of the M. africanum GM041182 genome
sequence has enabled the search for M. africanum-specific
sequences and the identification of M. africanum-specific pseudo-
genes.
We took advantage of the publicly available Illumina sequenc-
ing data for 23 strains representative of the MTBC including the
sequences of two lab-adapted strains, M. tuberculosis H37Rv and M.
bovis Ravenel, as well as the sequence of a strain classified as M.
canetti which we used as an outgroup. We mapped the Illumina
short-reads to the newly generated M. africanum GM041182 and
called for high-confidence polymorphisms. After exclusion of those
SNP calls falling in PE/PPE genes and in phage-related regions of
the genomes we used an alignment of 9,699 ‘core’ SNP calls
(positions in the genome of M. africanum GM041182 where at least
one strain has a SNP and no strain has a putative deletion or
heterozygous call). The resulting phylogeny (Figure 1) placed M.
africanum GM041182 as part of the M. africanum West-African 2
clade (also known as Lineage 6), clustered closely to another strain
originally isolated in The Gambia (GM0981). The phylogeny also
reflects the great diversity of human M. tuberculosis complex strains
found in West African countries with circulating strains from at
least three different lineages; the two M. africanum clades and
different sub-lineages belonging to the Euro-American lineage
(Lineage 4) which are thought to be recently re-introduced in
Africa, as the Euro-American lineage is supposed to have
originated in the European region [14].
Lineage-specific pseudogenes
It has been proposed that due to historical migrations and the
low-infectious dose during aerosol transmission of human
tuberculosis the effective population size of the bacilli could be
reduced. This phenomenon could lead to increased genetic drift,
limiting the removal of detrimental mutations through natural
selection. Relaxed selection can also act during adaptation to a
new niche on those genes for which a selective advantage for
maintenance is lost; alternatively, the gene function has become
disadvantageous in the new niche. Through base-level inspection
of the genome sequences we identified pseudogenes in M. africanum
GM041182 and verified pseudogene annotation in M. tuberculosis
H37Rv and M. bovis AF2122/97. We identified 120 pseudogenes
across the three genomes (M. africanum GM041182, M. tuberculosis
H37Rv, M. bovis AF2122/97); 20 were in PE-PGRS/PPE family
CDSs and in insertion sequence element transposase genes. Both
PE-PGRS/PPE family CDSs and insertion sequence elements are
known to be associated with intra-genomic recombination and are
susceptible to gene disruption [32,33,34].
We compared the remaining candidate pseudogenes with
available draft genomes from different strains belonging to the
MTBC lineages and the genome sequence of a M. canetti strain as
outgroup. By using an outgroup we could determine the genotype
of the most likely common ancestor of the MTBC for the different
candidate pseudogenes and determine which ones were shared by
other strains apart from M. africanum GM041182, M. tuberculosis
H37Rv, M. bovis AF2122/97 (Figure 2, Supplementary Table S2).
We found that some of the pseudogenes identified were strain-
specific occurring only in one of these three strains (20 in
GM041182, 7 in H37Rv and 9 in M. bovis). More importantly,
some of the pseudogene mutations were shared by a large group of
strains. For example, 12 were common to the M. africanum West-
African clade 2 and 13 common to both M. africanum clades.
Gene disruptions target redundant functions
In terms of function, the majority of pseudogenes are
hypothetical proteins (N=39), PE-PGRS family proteins and
phage-related (20), metabolic enzymes (13) and transcriptional
regulators (5) (Figure 3). Many seem to affect systems which are
likely to have functional redundancy due to the presence of
paralogous or analogous genes or pathways in the genome. For
example, there are three pathways for trehalose biosynthesis in
mycobacteria [35]; M. africanum and M. bovis each have a trehalose
biosynthesis pseudogene but are affected in different genes. M.
bovis treY, encoding maltooligosyltrehalose synthase, has a frame-
shift due to an internal 806bp deletion while M. africanum has a
nonsense mutation in a gene (MAF20180) which has been shown
to encode a trehalose-phosphate phosphatase. As a component of
cell-wall glycolipids, trehalose has been implicated in host tissue
damage [35]. Another example is the P450 family of enzymes:
there are 21 in the genome of M. africanum GM041182, two of
them, MAF35300 and MAF31280, are disrupted in all M.
africanum strains while another (MAF22860), which has been
shown to be essential for viability inM. tuberculosis, was identified in
M. africanum GM041182 [36]. Furthermore, of the 10 loci
containing at least one polyketide synthase gene, one is disrupted
in GM041182, another is disrupted in all West-African 2 clade
strains, and another in West-African 2 and animal strains.
The mycobacterial MmpL-family of proteins have a function in
lipid transport and have been shown to contribute to M. tuberculosis
intracellular survival [37]. Both clades of M. africanum, as well as
animal strains, carry the same nonsense mutation in the 39 end of
the mmpL12 gene (MAF15490) and in M. bovis the mmpL1 gene
(MAF04040) has a central frameshift. These mutations may be
predicted to impair lipid transport function, although the presence
of 12 mmpL paralogues per genome implies some degree of
redundancy. Another redundant system affected by mutation in
M. bovis is the so-called mammalian cell entry (mce) operons. M.
bovis has two adjacent pseudogenes (mce2D and mce2E) in one of the
four mce (mammalian cell entry) operons. In M. tuberculosis, deletion
of the mce2 operon attenuates the ability to infect mice [38], and
deletion of more than one mce operon has a cumulative effect
indicating non-redundant roles during infection [39].
Genome Sequence of M. africanum West African 2
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The ability to metabolize nitrate to nitrite is thought to be
important for M. tuberculosis to persist under anaerobic conditions
during dormancy and also appears to have functional redundancy
[40]. M. africanum GM041182 has a pseudogene relevant to nitrate
metabolism (narX) and all M. africanum and animal strains harbor a
narU pseudogene. Although the majority of nitrate reductase
activity in vitro is due to narGHJI [41], narX, which encodes a fusion
protein equivalent to parts of NarG, NarJ and NarI, has also been
shown to have a role in dormancy [40]. NarU is thought to be
involved in transport of nitrate into and nitrite out of the bacterial
cell though again its function is thought to be secondary to that of
the more active narK2 which coincidentally is adjacent to narX.
M. africanum West-African clade 2 strains have frameshift
mutations in one of the 17 adenylate cyclase genes in the genome
(MAF03880). InM. tuberculosis the MAF03880 orthologue (Rv0386)
was recently found to produce a cyclic AMP burst within
macrophages that influences cell signaling. Loss of Rv0386 resulted
in lower TNF-a induction, decreased immunopathology in animal
tissues, and diminished bacterial survival [42].
Three genes with a role in drug efflux have been disrupted; one
in M. africanum GM041182 strain (MAF03440), one in M. bovis
(orthologue of MAF18990) and one in all the so-called ‘modern’
MTBC strains (MAF23460). The isoniazid inducible gene, iniA
(MAF03440), thought to be involved in an efflux pump for two of
the 1st line TB drugs, isoniazid and ethambutol [43] has a 59
nonsense mutation inM. africanum GM041182. InM. tuberculosis an
iniA deletion mutant showed increased susceptibility to isoniazid
[43], suggesting that M. africanum may be more susceptible to
isoniazid than M. tuberculosis. This mutation is however not present
in other M. africanum strains of which the genome is available, nor
in clinical isolates of the same lineage originating from Burkina
Faso and Cote d’Ivoire (data not shown), suggesting that this
polymorphism is unique to strain GM041182 . Deletion of the M.
smegmatis orthologue of MAF18990 has been shown to result in
reduced resistance to ethidium bromide, acriflavine and erythro-
mycin [44]. More interesting is the evolution of the MAF23460
gene. Its homologue in H37Rv is Rv2333c. By inspecting the
alignment of both genes a single base pair deletion in the H37Rv
leads to a longer product than that observed in M. africanum
GM041182 strain (524 residues in M. africanum GM041182 versus
538 residues in M. tuberculosis H37Rv). By comparing with the rest
of strains of the complex it becomes clear that the single base
Figure 1. Position of GM041182 in the Mycobacterium tuberculosis complex genome phylogeny. The phylogenetic tree is based on the
mapping of Illumina data for representative strains of the complex to the newly generated M. africanum GM041182. The phylogeny was
reconstructed using Neighbor-joining and is based on 9,699 variable positions in at least one strain. One thousand bootstrap pseudo-replicates were
used to assess clade reliability. All nodes had more than 90% support. The positions of RD900h and RD900h are indicated. Numbers in branches refers
to the corresponding number of SNPs inferred. Lineage names are according Hersbergh 2008 while numbers are according to Comas et al. 2010. A
review of the nomenclature and comparison with other typing systems can be found in Coscolla and Gagneux 2010 [70] and Comas et al. 2009 [71].
doi:10.1371/journal.pntd.0001552.g001
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deletion occurred in the common ancestor of ‘modern’ lineages
representing in this case a possible gain of function rather than a
pseudogenetization per se of the ancestral genes. Rv2333c has
been shown to be involved in export of spectinomycin and
tetracycline and thus contributes to the intrinsic resistance of M.
tuberculosis to these antibiotics [45], which may thus be more
effective against M. africanum.
Further pseudogenes affect non-redundant systems such as
biosynthesis of vitamins B12 (cobalamin) and B6; three genes in a
cobalamin biosynthesis operon (MAF20880, MAF20850 and
MAF20870) have the same pseudogene allele in both M. africanum
and M. bovis while the pdxH (MAF26250) vitamin B6 biosynthesis
gene has a central frameshift mutation in M. africanum GM041822
strain. Supplementation of these vitamins may support growth of
M. africanum and reduce the growth delay ofM. africanum relative to
M. tuberculosis.
A notable non-redundant pseudogene is the previously
identified orthologue of Rv3879c (MAF38940), part of the RD1
region [46], that was found to be essential for ESAT-6 secretion,
but not CFP-10, inM. marinum but not inM. tuberculosis. In a recent
study using immunoblots for ESAT-6 and control antigens, we
found ESAT-6 secretion to be similar between M. africanum
GM041182, M. africanum GM041182 complemented with
Rv3879c, and M. tuberculosis H37Rv [47], which does not
Figure 2. Number of pseudogene events that occurred in the different lineages of the M. tuberculosis complex. As the initial number of
events was inferred from a three way comparison (see text for details) the number observed is a subset of all possible events that have happened in
the evolution of the MTBC. Colours in the figure represent the different lineages of the MTBC as defined in Figure 1. Green: M. africanum West African
2 (Lineage 6), Brown: M. africanum West African 1 (Lineage 5), Red: M. tuberculosis Euro-American (Lineage 4), Purple: M. tuberculosis India and East
Africa (Lineage 3), Blue: M. tuberculosis East Asia (Lineage 2), Pink: M. tuberculosis The Philippines and Rim of Indian Ocean (Lineage 1).
doi:10.1371/journal.pntd.0001552.g002
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corroborate the attenuated ESAT-6 response in M. africanum
infected people [11]. Given the ESX-1 homology throughout the
MTBC it is currently not clear how equal amounts of secreted
ESAT-6 between M. africanum GM041182 and M. tuberculosis
H37Rv can correlate with the attenuated ESAT-6 response
observed in M. africanum infected people. Ongoing immunoepide-
miological analyses however suggest that the attenuated ESAT-6
phenotype may cluster with sub-lineages within the M. africanum
West African 2 lineage. In addition, we identified a deletion in the
upstream regulatory region of Rv3616c whose expression is related
with ESAT-6 secretion [48]. This polymorphism in GM041182 is
shared with animal strains, in which it is responsible for decreased
expression of Rv3616c (Roger Buxton, personal communication).
Interestingly, ESAT-6 is highly immunogenic in M. bovis infected
cows [49], suggesting that the genetic basis for the attenuated
ESAT-6 response observed in M. africanum infected persons is
specific to M. africanum.
Finally, the M. tuberculosis orthologue of MAF29630 (Rv2958c)
encodes a glycosyl transferase which has been shown, in a co-
infection assay, to confer increased resistance to killing by human
macrophages [50]. Both M. africanum clades and M. bovis have a
single base pair insertion that shortens the gene product (367
residues in M. africanum GM041182 versus 429 residues in M.
tuberculosis H37Rv).
Identification of a lineage-specific sequence - RD900
On comparative genomics of M. bovis and M. tuberculosis H37Rv,
a region unique to M. bovis was designated TB deleted 1 (TbD1)
[51]. Subsequent work identified the TbD1 deletion to be shared
by ‘‘modern’’ M. tuberculosis lineages, with an intact TbD1 region
in other animal strains, M. africanum, and ‘‘ancient’’ M. tuberculosis
[15]. Proteins from the TbD1 region were however not
immunogenic in an ELISPOT assay that aimed to identify lineage
specific immune responses [52].
Comparison of the M. africanum GM041182 genome with
reference shotgun sequences for M. bovis (strains BCG Pasteur
1173P2, BCG Tokyo 172, AF2122/97) and M. tuberculosis (strains
H37Rv, H37Ra, CDC1551, F11) genomes revealed a single
region present in M. africanum GM041182 but deleted in M. bovis
and ‘‘modern’’ M. tuberculosis strains. This M. africanum specific
locus was designated RD900. The locus is 3,141 bp long and
contains a single complete gene (designated maf1 (MAF12860)) and
the 39 end of another (MAF12870); maf1 encodes a putative ATP-
binding cassette (ABC) transport protein that has a central ATP-
binding domain and six possible membrane-spanning domains in
the C-terminal portion. In addition the N-terminal region contains
a putative Forkhead associated (FHA) domain that may confer the
ability to bind DNA and thereby potentially act as a transcrip-
tional regulator. The LpqY-SugA-SugB-SugC ABC transporter
(Rv1235-Rv1238), one of four ABC transporters in M. tuberculosis,
has recently been characterized as a recycling system mediating
the retrograde transport of the sugar trehalose produced and
released by the bacterium [53]. Other ABC transport proteins
may mediate efflux of drugs and other compounds (Rv1218c,
[54]), with implications for immune responses (Rv1280c-Rv1283c,
[55]).
Of the 51 proteins in the Pfam database with the same domain
architecture as RD900, only twelve are from outside the order
Actinomycetales (seven from Cyanobacteria and five from
Chloroflexi); none have been experimentally characterised.
Assuming complete absence of recombination, comparison of
the RD900 region of M. africanum GM041182 with all available
genomes from the Mycobacterium tuberculosis complex suggests that
intact RD900 (M. africanum GM041182) represents the ancestral
Figure 3. Distribution of the number of pseudogene events by functional category. Clusters of Orthologous Groups (COG) categories were
derived from the NCBI M. tuberculosis H37Rv annotation while essential/non-essential classification was derived from experiments on transposon
mutagenesis [72,73].
doi:10.1371/journal.pntd.0001552.g003
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state of this region and the RD900 region was independently
deleted in two lineages: the ‘‘modern’’ M. tuberculosis lineage and a
sub-branch of the animal associated lineage leading to M. bovis
(Figure 1). We checked this in two ways. First, we aligned complete
genomes available for the MTBC with M. africanum GM041182.
Secondly, we did local BLAST searches of the region including the
two flanking genes (from MAF12850 to MAF12880) (see Figure 4).
The very unusual occurrence of independent deletions generating
the same functional gene, pknH, is explainable when the flanking
regions are considered.
In M. africanum GM041182, maf1 is flanked by similar, co-
directional genes, each encoding a protein kinase. The RD900
deletion appears to have been generated by recombination
between these flanking genes to form pknH, a protein kinase-
encoding gene found inM. bovis andM. tuberculosis (Figure 2a), thus
pknH is apparently a composite gene made up by intra-genomic
recombination between two homologous, physically close, genes.
Accordingly we have designated the flanking genes in M. africanum
GM041182 as pknH1 (downstream) and pknH2 (upstream). These
flanking CDSs in M. africanum GM041182 have a high level of
amino acid identity for the first two-thirds of their length
(Figure 2b) followed by divergent sequences from codon 424
(PknH1) and 373 (PknH2), onwards. However, the homologous
regions of PknH1 and PknH2 inM. africanum GM041182 have two
significant differences. The first is a 21 amino acid sequence
insertion/deletion region, present in PknH1 from codons 194 to
214 but absent from PknH2. The second is a substitution region of
53 amino acids in PknH1 (298–350) with low identity to a region
of 23 amino acids in PknH2 (277–299). These two differences
account for the 50 codon difference in the region of high identity
between PknH1 and PknH2. More importantly, the substitution
region can be used to demonstrate that the deletion of the pknH
gene in M. tuberculosis (called RD900h, Figure 1) was independent
of the RD900 deletion found in M. bovis (RD900a, Figure 1).
Deletion RD900h generates a composite pknH gene in M.
tuberculosis identical to M. africanum pknH1 in the substitution
region while the RD900a deletion found in M. bovis generates a
composite pknH gene with a substitution region identical to that of
M. africanum pknH2. This implies that the RD900h and RD900a
deletions had end points before and after the substitution region,
respectively. The remaining 39 portion of pknH for M. tuberculosis
and M. bovis has a high degree of similarity to M. africanum pknH1,
consistent with the architecture of the region in M. africanum.
The formation of an intact protein kinase in M. tuberculosis and
M. bovis, where deletion could easily have resulted in two non-
functional gene fragments, could be used to suggest a selective
advantage for the reduction in the number of protein kinases
caused by the RD900 deletion. However, this conclusion must be
tempered by the ease with which this deletion can be generated.
We assume that at least one functional pknH gene is required by
strains of the M. tuberculosis complex so it is not unexpected that
extant strains appear to have a functional gene at this locus.
Broadening the phylogenetic scope of the analysis to include
complete genomes from other members of the genus Mycobacterium
reveals further patterns of mycobacterial genome evolution
associated with RD900. It seems plausible that the ancestral
chromosome arrangement for the clade including the M.
tuberculosis and M. avium complexes was similar to that seen in M.
marinum where an extra 13,772 bp flanks the pknH2 side of RD900
(Figure 5). This flanking region ends with another protein kinase
gene which we designate here as pknH3 and the M. tuberculosis
complex ancestral genome may have undergone a deletion due to
recombination between pknH2 and pknH3.
The M. ulcerans Agy99 genome appears to have undergone the
deletion of MURD111 (which removes pknH2) and a long-range
rearrangement separating pknH1 and maf1 on the left flank from
the right hand flank which actually carries pknH3.
The genomes of M. avium and M. avium subspecies paratuberculosis
have simple RD900 deletions akin to those seen in the modern M.
tuberculosis and M. bovis lineages; M. leprae TN genome has a similar
deletion pattern but with extra DNA loss equivalent to the region
from 1412285 to 1423476 in M. africanum GM041182, which
results in the loss of nine genes including pknH1, maf1 and pknH2.
Curiously, M. smegmatis has a similar deletion pattern to M. leprae
suggesting a convergent event in this distant ‘‘rapid growing’’
relative. Also interesting is the high degree of synteny between M.
africanum GM041182 andM. kansasii ATCC 12478 with equivalent
RD900 arrangement and colinearity extending for at least 6
kilobases on both flanks.
Discussion
The M. africanum GM041182 genome is, as expected, highly
homologous to those of other members of the M. tuberculosis
complex, yet contains a unique sequence, RD900, that was
independently lost during the evolution of two important lineages
within the complex; the ‘‘modern’’ M. tuberculosis group and the
lineage leading to M. bovis. In addition, RD900 is variably present
in atypical mycobacteria, with evidence for repeated independent
deletion events. We can expect to learn more about the
phylogenetic position of this deletion as more mycobacterial
genomes are sequenced, with this complete M. africanum West
African 2 sequence serving as an alternative reference for the
mapping of further M. africanum genomes generated using Next
Generation Sequencing techniques. Determining the function of
the deleted gene, maf1, and the phenotypic consequences of its
deletion will require further study but nevertheless this occurrence
may provide valuable insight into the evolution of the complex.
The similarity in pseudogene repertoire suggests that M.
africanum has a similar evolutionary history to M. bovis and it is
tempting to speculate that this may have involved adaptation to a
non-human animal host, though it must be noted that for both
lineages nearly half of the pseudogenes are unique, so subsequent
adaptations may have occurred since their divergence reflecting
contemporary niche differences. Thus far, no candidate animal
reservoir has been detected for M. africanum. Extensive searches
among cattle, sheep, pigs, and goats in the Gambia and
neighbouring countries have not identified mycobacterial infection
nor disease [16,56,57]. Phylogenetically, the Dassie bacillus [58]
and the recently identified Mycobacterium mungi [59], are the closest
relatives of M. africanum within the M. tuberculosis complex. The
Dassie bacillus has been isolated from Dassies, or Rock Hyrax, in
Figure 4. A. Comparison of the RD900 locus in M. bovis, M. africanum and M. tuberculosis. The RD900 deletion is present in M. bovis
(AF212297)and M tuberculosis (H37Rv) identified through a genome comparison with M. africanum (GM041182). Figure adapted from use of Artemis
Comparison Tool. B. Alignment of PknH1 and PknH2 in M. africanum (GM041182). The first two thirds of PknH1 and PknH2 have a high level of
sequence identity except for two distinct regions. The first region is an INDEL region from codons 194–214 in PknH1. The second is a substitution
region where there are 53 amino acids in PknH1 (green) instead of a region of 23 amino acids in PknH2 (red). The substitution region allows us to
identify two different RD900 deletions; RD900h in M. tuberculosis, and RD900a in M. bovis. C. Alignment of the substitution region of the PknH gene of
M. tuberculosis and M. bovis. A different composite PknH gene has resulted from two different RD900 deletions described in B.
doi:10.1371/journal.pntd.0001552.g004
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South Africa [60], and M. mungi causes disease in troops of banded
mongoose in northern Botswana [59]. However, an extensive
search for mycobacteria in terrestrial small mammals in Benin,
West Africa, did not identify any members of the M. tuberculosis
complex [61].
The lack of spread of M. africanum from West Africa to the
Americas at the time of the slave trade remains enigmatic. Today,
M. africanum is rarely isolated outside of West Africa, typically in
first degree immigrants [62]. In a study in Ghana, host
polymorphisms were identified with differential protection against
M. tuberculosis versus M. africanum in both directions [63,64],
although the degree of selective advantage conferred by these
polymorphisms is unclear.
The majority of the pseudogenes detected are only disrupted by
a single base mutation, either by an insertion/deletion leading to a
frameshift or by substitution leading to a nonsense mutation. As
expected for a recently evolved pathogen no further disrupting
mutations have been identified in the pseudogenes. Similarly, in a
comparison of several MTBC genomes that included GM041182,
no mutations were identified in the promoter region of the
pseudogenes, supporting the notion that ‘‘pseudogenization’’ in
the MTBC is recent [65]. A formal statistical testing of the rate of
acquisition of pseudogenes cannot be carried out because of the
bias in the discovery of the pseudogenes described to those
observed in the comparison of M. africanum GM041182 with the
two other strains leading to a phenomenon of pseudogene
discovery bias.
However, the high number of pseudogenes in M. africanum and
other strains of the M. tuberculosis complex (MTBC) suggest that
genome erosion is ongoing. Most likely this reflects several different
phenomena that have lead to the downsizing of the MTBC
genomes as compared to other free-living or opportunistic
Mycobacteria [66,67]. This could be partly due to its recent
evolution as an intracellular pathogen, making some functions that
served a free-living lifestyle redundant to the MTBC, which was
therefore prone to lose the function due to relaxed selection. At the
same time natural selection can act to favour the loss of some genes.
These ‘‘anti-virulence genes’’ can be lost because they can be
detrimental for the pathogenic lifestyle as has been described for
other species [68] and suggested for some known deletion events in
the MTBC [69]. Finally, the increased genetic drift imposed by
transmission bottlenecks and changes in population size of its host,
lead to a weakened effect of natural selection and increased
accumulation of functional mutations, many of them detrimental
[14]. Further studies, such as complementing the virulence gene
Rv0386 in M. africanum and assessing the effect in the appropriate
animal model, can assess to which extent its lower progression to
disease is explained by these pseudogenes. Moreover, the presence
in M. africanum GM041182 of the original version of MAF23460
(Rv2333c) without gain of function suggests that M. africanum (and
other ancestral M. tuberculosis complex lineages) lack this functional
efflux pump and may be more susceptible to antibiotics, possibly
including spectinomycin and tetracycline.
Differentiating these processes by comparative genomics within
and outside the complex could provide clues about how the tight
relationships between MTBC species and their respective hosts
arose in the first place, and how the ongoing erosion described
here generates different genetic backgrounds within the complex
than can explain some of the differences associated with diversity
in disease outcome [70].
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Figure 5. The RD900 locus in other mycobacteria. RD900 region is deleted in both M. tuberculosis (H37Rv) and M. bovis (AF212297) but not M.
africanum (GM041182) M. canetti (CIPT140010059), M. marinum (M) or M. ulcerans (Agy99). In M. marinum an additional PknH gene is present
(designated as PknH3). PknH3 is also present in M. ulcerans, where the PknH1 locus and a 59 CDS (grey) have been duplicated/translocated to
somewhere else in the genome (position 4951200–4955915). The entire ‘‘ancestral’’ PknH locus is not present. PknH genes were identified through
comparative genome comparison of available shotgun sequences.
doi:10.1371/journal.pntd.0001552.g005
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